Ying Vivian Liu - Apr 27, 2023 Form 4 Insider Report for ContextLogic Inc. (WISH)

Role: CFO and COO
Signature: /s/ Marianne Lewis, Attorney-in-Fact
Stock symbol: WISH
Transactions as of: Apr 27, 2023
Transactions value $: $0
Form type: 4
Date filed: 5/1/2023, 06:02 PM
Previous filing: Mar 10, 2023
Next filing: May 17, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	WISH	Restricted Stock Unit	Award	$0	+119K		$0.00	119K	Apr 27, 2023	Class A Common Stock	119K		Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The Reporting Person was granted restricted stock units ("RSUs") which represent a contingent right to receive one share of Issuer's Class A Common Stock for each RSU.
F2	Subject to the Reporting Person's continuous service, 10% of the RSUs will vest on a quarterly basis beginning on May 15, 2023 (with all quarterly vesting events occurring on a "Company Vesting Date" of February 15, May 15, August 15, or November 15). Vested RSUs will settle on or following the vesting date, but in any event within 60 days following the vesting date (unless the Reporting Person and the Company have agreed in writing to a later settlement date pursuant to procedures the Company may prescribe at its discretion).

Content

The Reporting Person was granted restricted stock units ("RSUs") which represent a contingent right to receive one share of Issuer's Class A Common Stock for each RSU.

Subject to the Reporting Person's continuous service, 10% of the RSUs will vest on a quarterly basis beginning on May 15, 2023 (with all quarterly vesting events occurring on a "Company Vesting Date" of February 15, May 15, August 15, or November 15). Vested RSUs will settle on or following the vesting date, but in any event within 60 days following the vesting date (unless the Reporting Person and the Company have agreed in writing to a later settlement date pursuant to procedures the Company may prescribe at its discretion).